Comparison of SARS-CoV-2 RT-PCR on a high-throughput molecular diagnostic platform and the cobas SARS-CoV-2 test for the diagnostic of COVID-19 on various clinical samples
2020; Oxford University Press; Volume: 78; Issue: 8 Linguagem: Inglês
10.1093/femspd/ftaa061
ISSN2049-632X
AutoresOnya Opota, René Brouillet, Gilbert Greub, Katia Jaton,
Tópico(s)COVID-19 diagnosis using AI
ResumoIn order to cope with the rapid spread of the COVID-19 pandemic, we introduced on our in-house high-throughput molecular diagnostic platform (MDx Platform) a real-time reverse transcriptase PCR (RT-PCR) to detect the SARS-CoV-2 from any clinical specimens. The aim of this study was to compare the RT-PCR results obtain with the MDx Platform and the commercial assay cobas SARS-CoV-2 (Roche) on nasopharyngeal swab and other clinical specimens including sputum, bronchial aspirate, bronchoalveolar lavage and anal swabs.
Referência(s)